QGEN's logo.
Ticker Symbol: QGEN

Qiagen NV

$55.57 - 20-12-2024 4 p.m. ET

Exchange: NEW YORK STOCK EXCHANGE INC. Country: Netherlands Currency: USD Asset Type: Common Stock CIK:0001015820

Company Profile

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31, 2020, QIAGEN employed more than 5,600 people in over 35 locations worldwide.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: Hulsterweg 82
CEO: Thierry Bernard
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $38.46
Change: -$0.61 ( -1.56%)
Days Range: $38.14 - $38.75
Beta: 0.60
52wk. High: $51.18
52wk. Low: $37.43
Ytd. Change -24.44%
50 Day Moving Average: $40.19
200 Day Moving Average: $44.11
Shares Outstanding: 228000000

Valuation

Market Cap: 876.9B
PE Ratio: 26.34
EPS (TTM): 1.46

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A